Kudos and Oxford PharmaGenesis collaborate

Kudos, the platform for showcasing research, has announced a collaboration with Oxford PharmaGenesis, a global leader in HealthScience communications. The partnership will help pharmaceutical, biotech, and healthcare research organisations take a more strategic approach to omnichannel communications by combining expertise in medical content and strategy from Oxford PharmaGenesis with the Kudos platform and audience.
Clients will benefit from more rapid delivery of microsites that bring evidence-led storytelling – through plain language summaries, clinical trial data, infographics, videos, prescribing information and more – to target audiences such as healthcare professionals, researchers and patients. Kudos also includes tools for planning, managing and measuring omnichannel communications. The partners say the Oxford PharmaGenesis ‘serviced edition’ of Kudos provides companies with an end-to-end package for creating, disseminating, and measuring the impact of medical content.
“Pharma and med affairs teams often face a fragmented communications landscape, where great content is created but struggles to reach the right audiences,” said Charlie Rapple, co-founder of Kudos. “This partnership solves that – bringing together strategy, execution, and a powerful platform to engage and inform with precision.”
“We’re excited to partner with Kudos to offer our current and prospective clients a new level of control and clarity over their communications,” said Chris Winchester, CEO of Oxford PharmaGenesis. “This is about helping our clients deliver measurable value – not just by reaching audiences, but by taking them on structured, evidence-based learning journeys.”
The partnership is built around a flexible package model, combining Kudos’ platform with Oxford PharmaGenesis’ services – from strategic communications planning through to content development and deployment. Use cases range from biotech firms communicating about a single product, to large pharmaceutical companies organising and optimising high volumes of medical content.